Meeta Gulyani

Meeta Gulyani has over two and half decades of international experience working with business-wide strategic development and implementation, driving large-scale transformation and delivering strong operating performance. In her most recent position for Millipore Sigma, the Life Science Division of Merck KGaA, Darmstadt, Germany, she was responsible for the organisation’s long-term strategy, business development and sustainability agenda. In addition, following the USD 17 Billion acquisition of the chemical giant Sigma-Aldrich, she led its successful integration. Meeta was previously the Head of Strategy and Global Franchises for the Biopharma business of Merck KGaA, Darmstadt, Germany.

Before joining Merck KGaA, Darmstadt Germany in 2014, Meeta served as General Manager for Roche South Asia, and Vice President, Head of Global Portfolio Management at Roche. In addition, she has held several marketing and sales leadership positions within Sanofi and served as a strategy consultant with the Monitor Consulting Group based in Hong Kong and the United States.

Since December 2021, Meeta has served on the Board of Directors of Seer, a life sciences company commercialising a disruptive new platform for proteomics. For the Life Science business of Merck, KGaA, Darmstadt, Germany, she was a member of the Executive and Deal Review Committees and also chaired the M Ventures Life Science board, the company’s strategic, corporate venture capital arm. She additionally held executive leadership positions at the Biopharma division of Merck KGaA, Darmstadt Germany and at Roche Pharma.